Hu, X., Zhou, Y., Hill, C., Chen, K., Cheng, C., Liu, X., . . . Wang, Y. (2024). Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification. Br J Cancer.
استشهاد بنمط شيكاغوHu, Xiaoxiao, et al. "Identification of MYCN Non-amplified Neuroblastoma Subgroups Points Towards Molecular Signatures for Precision Prognosis and Therapy Stratification." Br J Cancer 2024.
MLA استشهادHu, Xiaoxiao, et al. "Identification of MYCN Non-amplified Neuroblastoma Subgroups Points Towards Molecular Signatures for Precision Prognosis and Therapy Stratification." Br J Cancer 2024.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.